Why the study?
Does pleconaril reduce viral shedding and symptoms in adults with experimentally induced coxsackievirus A21 respiratory infection?
Does pleconaril reduce viral shedding and symptoms in adults with experimentally induced coxsackievirus A21 respiratory infection?
Pleconaril effectively reduces viral shedding and clinical symptoms in adults with experimentally induced coxsackievirus A21 respiratory infection.
No takes yet. Share an insight, caveat, or question.
Supports pleconaril for coxsackievirus A21 respiratory infections; extends RCT evidence from experimental models to clinical translation.
Schiff et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: